menu search

Eloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome

Eloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome
Globally renowned Alport syndrome experts will provide key insights Eloxx recently announced achievement of remission in one patient in its Phase 2 Alport syndrome clinical study and decision to advance into a pivotal trial in Alport syndrome WATERTOWN, Mass., June 21, 2023 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted […] The post Eloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome appeared first on ForexTV... Read More
Posted: Jun 21 2023, 17:30
Author Name: forextv
Views: 081164

Search within

Pages Search Results: